Drug intelligence / Profile preview

pyrrolnitrin

Development stage
Preclinical
Modality
Small Molecules
Administration
Topical
01

Overview

Pyrrolnitrin is a naturally occurring phenylpyrrole antifungal agent produced by certain Pseudomonas and Burkholderia species as a secondary metabolite from tryptophan[5][7]. It exhibits broad-spectrum antibiotic activity, particularly against dermatophytic fungi such as Trichophyton species, as well as other fungi, yeasts, and some gram-positive bacteria[1][3][4][8]. Pyrrolnitrin acts primarily by inhibiting the terminal electron transport system in fungal cells, thereby disrupting cellular respiration and energy production[1][5][8]. Its mechanism involves inhibition of the respiratory electron transport chain between succinate or NADH and coenzyme Q. This leads to immediate inhibition of both endogenous and exogenous respiration in susceptible organisms[8]. Pyrrolnitrin has served as a lead structure for synthetic fungicides like fenpiclonil and fludioxonil[5].

Other names
pirrolnitrinaPRN
02

Targets

ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on pyrrolnitrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pyrrolnitrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call